Company Filing History:
1 out of 1,603 
1 out of 18 
1 out of 832,812 Years Active: 1993-1997
Title: The Innovations of Philip Lake
Introduction
Philip Lake is a notable inventor based in Parsippany, NJ (US), recognized for his contributions to the field of medical science. He holds three patents that focus on advancements in monoclonal antibodies, particularly in relation to viral infections.
Latest Patents
His latest patents include a monoclonal antibody to the herpes simplex virus and a cell line producing the same. This invention involves human monoclonal antibodies effective for the diagnosis and treatment of Herpes Simplex Virus 1 and 2. These antibodies were prepared from a cell line obtained by fusing a xenogeneic hybridoma designated SPAZ 4 with spleen cells of a patient immune to the virus. Another significant patent involves human antibodies against the varicella-zoster virus. This invention provides human monoclonal antibodies specific for the glycoprotein II subunit of the virus. The preferred antibodies exhibit strong complement-independent neutralizing activity, antibody-dependent cellular cytotoxicity, and cross-reactivity with multiple strains of the varicella-zoster virus.
Career Highlights
Throughout his career, Philip Lake has worked with prominent companies such as Sandoz GmbH and Sandoz Pharmaceuticals Corp. His work has significantly impacted the development of therapeutic solutions for viral infections.
Collaborations
Some of his notable coworkers include Dean A Handley and Lars Ostberg. Their collaborative efforts have contributed to the advancements in the field of immunology.
Conclusion
Philip Lake's innovative work in the development of monoclonal antibodies has made a significant impact on the medical field, particularly in the diagnosis and treatment of viral infections. His contributions continue to influence research and development in this vital area of healthcare.